{
  "ticker": "LLY",
  "target_date": "2025-10-09",
  "actual_date": "2025-10-09",
  "collected_at": "2025-12-08T12:23:14.256159",
  "price": {
    "open": 850.44,
    "high": 858.99,
    "low": 844.46,
    "close": 854.0956420898438,
    "volume": 3071700,
    "change_1d_pct": 1.14,
    "change_7d_pct": 12.1,
    "change_30d_pct": 16.51
  },
  "technicals": {
    "rsi_14": 76.09,
    "sma_20": 778.39,
    "sma_50": 739.84,
    "macd": 29.207,
    "macd_signal": 19.153,
    "macd_histogram": 10.054,
    "bb_upper": 872.85,
    "bb_lower": 683.93,
    "price_vs_sma20_pct": 9.73,
    "price_vs_sma50_pct": 15.44,
    "volume_ratio": 0.77
  },
  "fundamentals": {
    "market_cap": 893149708288,
    "pe_ratio": 48.814846,
    "forward_pe": 43.967827,
    "price_to_book": 37.511707,
    "price_to_sales": 15.03118,
    "profit_margin": 30.99,
    "operating_margin": 48.29,
    "roe": 96.47,
    "roa": 17.6,
    "revenue_growth": 53.9,
    "earnings_growth": 480.4,
    "debt_to_equity": 178.516,
    "current_ratio": 1.546,
    "quick_ratio": 0.724,
    "dividend_yield": 59.0,
    "fifty_two_week_high": 1111.99,
    "fifty_two_week_low": 623.78,
    "fifty_day_avg": 911.5326,
    "two_hundred_day_avg": 811.9354,
    "analyst_target": 1056.7045,
    "analyst_recommendation": "buy",
    "num_analysts": 27,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - General",
    "pct_from_52w_high": -10.4,
    "pct_from_52w_low": 59.72
  },
  "macro": {
    "spy": {
      "price": 671.16,
      "change_1d_pct": -0.29,
      "change_7d_pct": 0.41
    },
    "vix": {
      "level": 16.43,
      "signal": "NORMAL"
    },
    "treasury_10y": {
      "yield_pct": 4.15
    },
    "dollar_index": {
      "level": 99.54
    },
    "gold": {
      "price": 3946.3
    },
    "regime": "BULL_NORMAL"
  },
  "news": [
    {
      "headline": "Eli Lilly (LLY) Gains As Market Dips: What You Should Know",
      "source": "Yahoo",
      "datetime": 1760046302,
      "summary": "Eli Lilly (LLY) reached $855.35 at the closing of the latest trading day, reflecting a +1.14% change compared to its last close.",
      "url": "https://finnhub.io/api/news?id=d28d171591dba28861da14a5820e7002d66b609afea7af1fd71968d65db10747"
    },
    {
      "headline": "A Major Eli Lilly Shareholder Has Sold Stock Nearly Every Day in October. Here\u2019s Who It Is.",
      "source": "Yahoo",
      "datetime": 1760037960,
      "summary": "A nonprofit founded by members of the Lilly family has been unloading  Eli Lilly  stock nearly every day since the start of the month.  Of the first six trading days in October, the Lilly Endowment has made sales on five of them.  The most recent transaction came on Oct. 7, when the Lilly Endowment ",
      "url": "https://finnhub.io/api/news?id=ae4422e734ed829f05ec717b21f6bd4ddb255dfbfd2b90bf6a6ca48bc869b4ef"
    },
    {
      "headline": "Novo Nordisk Is Buying Akero Therapeutics. It\u2019s More Good News for Biotech Stocks.",
      "source": "Yahoo",
      "datetime": 1760023020,
      "summary": "Novo said it would buy Akero for $54 a share in cash and an additional $6 if it gets U.S. approval of efruxifermin, it\u2019s treatment for fatty liver disease.",
      "url": "https://finnhub.io/api/news?id=f55c47e0c43348bceb07f18d30c3ccaf3d46f458e57a8f6f02e82be96385e339"
    },
    {
      "headline": "Is Novo Nordisk Stock a Sell Despite its 10% Price Rally in a Month?",
      "source": "Yahoo",
      "datetime": 1760022000,
      "summary": "NVO's 10% stock price rally masks deeper challenges as competition, restructuring and slower growth weigh on its outlook.",
      "url": "https://finnhub.io/api/news?id=d7ba63683943b878f7b70f9ddea1a2ad0bad6207dcb2f2f8fd7b56b705496b92"
    },
    {
      "headline": "AbbVie vs. Eli Lilly: Which Large Drugmaker Has the Edge in 2025?",
      "source": "Yahoo",
      "datetime": 1760019240,
      "summary": "Lilly's explosive GLP-1 growth and AbbVie's post-Humira rebound set up a fierce 2025 showdown between two pharma powerhouses.",
      "url": "https://finnhub.io/api/news?id=7a9f2523f52efcafe008ccb4dce422d8bdfa9797d514df51e044f9ad2751ea45"
    }
  ],
  "news_count": 5,
  "sec_filings": [
    {
      "form": "4",
      "date": "2025-10-09",
      "description": "xslF345X05/form4-10092025_041002.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000031601125000031/xslF345X05/form4-10092025_041002.xml"
    },
    {
      "form": "4",
      "date": "2025-10-08",
      "description": "xslF345X05/form4-10082025_041001.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000031601125000029/xslF345X05/form4-10082025_041001.xml"
    },
    {
      "form": "4",
      "date": "2025-10-07",
      "description": "xslF345X05/form4-10072025_041001.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000031601125000027/xslF345X05/form4-10072025_041001.xml"
    },
    {
      "form": "4",
      "date": "2025-10-06",
      "description": "xslF345X05/form4-10062025_041001.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000031601125000025/xslF345X05/form4-10062025_041001.xml"
    },
    {
      "form": "4",
      "date": "2025-10-03",
      "description": "xslF345X05/form4-10032025_041001.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000031601125000021/xslF345X05/form4-10032025_041001.xml"
    }
  ],
  "sec_filings_count": 5,
  "data_quality": {
    "has_price": true,
    "has_technicals": true,
    "has_fundamentals": true,
    "has_macro": true,
    "has_news": true,
    "has_sec_filings": true
  }
}